Norgine B.V. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: November 21, 2014
Pages: 47
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: NAC25D9E314EN
Leaflet:

Download PDF Leaflet

Norgine B.V. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Norgine BV (Norgine) is a pharmaceutical company. The company manufactures and markets pharmaceutical products. It operates in three core therapy areas: gastroenterology, hepatology, critical and supportive care. Norgine’s products include axid nizaxid, camcolit, dantrium dantrolen iv, destolit, fivasa, giprocol, givalex, klean-prep, quadrasa, among others. The company’s products are used for treatment of gastroenterology, antipsychotic, supportive care, respiratory tract – upper, critical and supportive care and protein supplement / therapy. Its partners include Access Pharmaceuticals Inc., Alizyme, Ajinomoto, SpePharm, Takeda, Tranzyme, Tillotts, Merck Sante France, Medical Futures, Modi-Mundipharma, Jubilant Biosys, among others. Norgine is headquartered in Amsterdam, the Netherlands.

Norgine B.V. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Norgine B.V., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Norgine B.V., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
Norgine B.V., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Norgine B.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Norgine B.V., Medical Devices Deals, 2008 to YTD 2014
Norgine B.V., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
Norgine B.V., Pharmaceuticals & Healthcare, Deal Details
Asset Purchase
Norgine Acquires Cetilistat From Alizyme Therapeutics
Partnerships
Altacor Enters Into Co-Promotion Agreement With Norgine For Clinitas Dry Eye Product
Norgine Forms Joint Venture With SpePharm Holding
Norgine Expands Distribution Agreement With PharmaSwiss For Movicol
Norgine Enters Into Drug Discovery Agreement With Jubilant
Norgine Enters Into Co-Marketing Agreement With Modi Mundipharma
Norgine Enters Into Co-Marketing Agreement With Alfa Wassermann
Norgine Enters Into Co-Marketing Agreement With PharmaSwiss For Moviprep
Phynova Group Enters Into Agreement With Norgine
Licensing Agreements
PlasmaTech Biopharma Expands Licensing Agreement with Norgine for MuGard
Access Pharma Enters into Licensing Agreement with Norgine for MuGard
Norgine Enters Into Licensing Agreement With Innovacell For ICEF15
Norgine Enters Into Licensing Agreement With Pegasus Biosolutions
Norgine Expands Licensing Agreement With Medical Futures For NORMACOL
APR Applied Pharma Research And Labtec Enters Into Licensing Agreement With Norgine For Setofilm
Nycomed Enters Into Licensing Agreement With Norgine For MOVIPREP
Salix Pharma And Norgine Enter Into Licensing Agreement With Novel Labs
Tranzyme Pharma Enters Into Licensing Agreement With Norgine
Santarus Enters Into Licensing Agreement With Norgine
Norgine Enters Into A Licensing Agreement With L’Institut National Recherche Agronomique
Norgine Enters Into Licensing Agreement With Medical Futures For MOVIPREP
Norgine Enters Into Licensing Agreement With Ajinomoto
Norgine Enters Into Licensing Agreement With Alizyme
Asset Transactions
Meda Acquires Pyralvex, Spasmonal And Waxsol From Norgine
Acquisition
Norgine Acquires 12.61% Stake In ProStrakan
Norgine B.V. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Norgine B.V., Pharmaceuticals & Healthcare, Key Facts
Norgine B.V., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Norgine B.V., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
Norgine B.V., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Norgine B.V., Deals By Therapy Area, 2008 to YTD 2014
Norgine B.V., Medical Devices Deals, 2008 to YTD 2014
Norgine B.V., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
Norgine Acquires Cetilistat From Alizyme Therapeutics
Altacor Enters Into Co-Promotion Agreement With Norgine For Clinitas Dry Eye Product
Norgine Forms Joint Venture With SpePharm Holding
Norgine Expands Distribution Agreement With PharmaSwiss For Movicol
Norgine Enters Into Drug Discovery Agreement With Jubilant
Norgine Enters Into Co-Marketing Agreement With Modi Mundipharma
Norgine Enters Into Co-Marketing Agreement With Alfa Wassermann
Norgine Enters Into Co-Marketing Agreement With PharmaSwiss For Moviprep
Phynova Group Enters Into Agreement With Norgine
PlasmaTech Biopharma Expands Licensing Agreement with Norgine for MuGard
Access Pharma Enters into Licensing Agreement with Norgine for MuGard
Norgine Enters Into Licensing Agreement With Innovacell For ICEF15
Norgine Enters Into Licensing Agreement With Pegasus Biosolutions
Norgine Expands Licensing Agreement With Medical Futures For NORMACOL
APR Applied Pharma Research And Labtec Enters Into Licensing Agreement With Norgine For Setofilm
Nycomed Enters Into Licensing Agreement With Norgine For MOVIPREP
Salix Pharma And Norgine Enter Into Licensing Agreement With Novel Labs
Tranzyme Pharma Enters Into Licensing Agreement With Norgine
Santarus Enters Into Licensing Agreement With Norgine
Norgine Enters Into A Licensing Agreement With L’Institut National Recherche Agronomique
Norgine Enters Into Licensing Agreement With Medical Futures For MOVIPREP
Norgine Enters Into Licensing Agreement With Ajinomoto
Norgine Enters Into Licensing Agreement With Alizyme
Meda Acquires Pyralvex, Spasmonal And Waxsol From Norgine
Norgine Acquires 12.61% Stake In ProStrakan
Norgine B.V., Key Competitors
Norgine B.V., Key Employees
Norgine B.V., Subsidiaries

LIST OF FIGURES

Norgine B.V., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Norgine B.V., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Norgine B.V., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Norgine B.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Norgine B.V., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Norgine B.V., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Norgine B.V., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Norgine B.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Norgine B.V., Medical Devices Deals, 2008 to YTD 2014
Skip to top


Ask Your Question

Norgine B.V. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: